Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application
The ACR/EULAR classification criteria for systemic sclerosis (SSc) entail three autoantibodies: anti-centromere antibodies (ACA), anti-topoisomerase I antibodies (ATA), and anti-RNA-polymerase III antibodies (ARA). The importance of ACA and ATA in the classification criteria is evidence based, but t...
Main Authors: | Jan Damoiseaux, Judith Potjewijd, Ruben L. Smeets, Carolien Bonroy |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Journal of Translational Autoimmunity |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589909022000028 |
Similar Items
-
Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-up
by: Carolien Bonroy, et al.
Published: (2022-01-01) -
Autoantibody profiles in systemic sclerosis; a comparison of diagnostic tests
by: Wynand Alkema, et al.
Published: (2021-04-01) -
Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update
by: Elvis Hysa, et al.
Published: (2023-01-01) -
Associations of autoantibodies and clinical profile of the patients with systemic sclerosis
by: Shahin Mahmud, et al.
Published: (2022-09-01) -
AUTOANTIBODIES IN SYSTEMIC SCLEROSIS: SPECTRUM, CLINICAL ASSOCIATIONS, AND PROGNOSTIC VALUE
by: L. P. Ananyeva, et al.
Published: (2016-03-01)